Bifogade filer
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Bioteknik |
2024-06-28 11:47:40
OSLO, 28 June 2024: EXACT Therapeutics AS ("EXACT-Tx", "the Company" Euronext
Growth: EXTX) held its Annual General Meeting on June 28th 2024 at 10:30 CEST.
All proposed resolutions were approved.
Please find enclosed the minutes of the meeting including appendices. The
minutes will also be available on the company website: www.exact-tx.com
ENDS
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
John M. Edminson CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com
About EXACT-Tx
EXACT-Tx is a clinical-stage Norwegian precision health company developing a
technology platform for targeted therapeutic enhancement - Acoustic Cluster
Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted
drug enhancement - with the potential to enable or significantly amplify the
clinical utility of a wide range of therapeutic agents across a multitude of
indications including within oncology (chemotherapy, immunotherapy) and brain
diseases. www.exact-tx.com